A landmark study led by the Wellcome Sanger Institute has fundamentally altered the scientific understanding of how chronic myeloid leukemia…
Read More

A landmark study led by the Wellcome Sanger Institute has fundamentally altered the scientific understanding of how chronic myeloid leukemia…
Read More
The landscape of ophthalmological treatments is on the cusp of a profound transformation, spearheaded by groundbreaking research from the National…
Read More
Eli Lilly and Company is embarking on a significant acquisition spree, exemplified by its recent agreement to acquire Kelonia Therapeutics…
Read More
In a landmark study that may redefine the scientific understanding of how the body grows old, researchers have identified a…
Read More
The pursuit of next-generation wearable electronics, ranging from augmented reality (AR) glasses that look like standard spectacles to sophisticated smart…
Read More
Eli Lilly and Company has forged a significant licensing agreement with South Korean biopharmaceutical firm Hanmi Pharm, potentially worth up…
Read More
Python’s pervasive influence across the data science landscape is not merely a trend but a testament to its highly expressive…
Read More
Scientists studying the remarkable regenerative capabilities of axolotls, zebrafish, and mice have identified a common genetic pathway that could pave…
Read More
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
Over the past 16 months, Chinese-domiciled biopharmaceutical companies have emerged as significant players in the global drug development landscape, participating…
Read More